Corkery, John Martin

Novel psychoactive substances of interest for psychiatry

Schifano, F., Orsolini, L., Duccio Papanti, G., & Corkery, J. M. (2015) · World Psychiatry

Forensic Toxicology and Drug AnalysisPsychedelics and Drug Studies

Cited by 321

An Insight into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions

Schifano, F., Chiappini, S., Corkery, J. M., & Guirguis, A. (2019) · International Journal of Neuropsychopharmacology

Pharmacovigilance and Adverse Drug ReactionsSubstance Abuse Treatment and Outcomes

Cited by 194

New/emerging psychoactive substances and associated psychopathological consequences

Schifano, F., Napoletano, F., Chiappini, S., Guirguis, A., Corkery, J. M., Bonaccorso, S., Ricciardi, A., Scherbaum, N., & Vento, A. (2021) · Psychological Medicine

Forensic Toxicology and Drug AnalysisPsychedelics and Drug Studies

Cited by 119

GLP-1 Receptor Agonists and Related Mental Health Issues; Insights from a Range of Social Media Platforms Using a Mixed-Methods Approach

Arillotta, D., Floresta, G., Guirguis, A., Corkery, J. M., Catalani, V., Martinotti, G., Sensi, S. L., & Schifano, F. (2023) · Brain Sciences

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 104

The “Endless Trip” among the NPS Users: Psychopathology and Psychopharmacology in the Hallucinogen-Persisting Perception Disorder. A Systematic Review

Orsolini, L., Papanti, G. D., De Berardis, D., Guirguis, A., Corkery, J. M., & Schifano, F. (2017) · Frontiers in Psychiatry

Psychedelics and Drug StudiesHallucinations in medical conditions

Cited by 99

Gamma hydroxybutyrate (GHB), gamma butyrolactone (GBL) and 1,4-butanediol (1,4-BD; BDO): A literature review with a focus on UK fatalities related to non-medical use

Corkery, J. M., Loi, B., Claridge, H., Goodair, C., Corazza, O., Elliott, S., & Schifano, F. (2015) · Neuroscience & Biobehavioral Reviews

Forensic Toxicology and Drug AnalysisSubstance Abuse Treatment and Outcomes

Cited by 98

Is There a Risk for Semaglutide Misuse? Focus on the Food and Drug Administration’s FDA Adverse Events Reporting System (FAERS) Pharmacovigilance Dataset

Chiappini, S., Vickers-Smith, R., Harris, D., Papanti Pelletier, G. D., Corkery, J. M., Guirguis, A., Martinotti, G., Sensi, S. L., & Schifano, F. (2023) · Pharmaceuticals

Pharmacovigilance and Adverse Drug ReactionsPharmacology and Obesity Treatment

Cited by 78

The clinical challenges of synthetic cathinones

Schifano, F., Napoletano, F., Arillotta, D., Zangani, C., Gilgar, L., Guirguis, A., Corkery, J. M., & Vento, A. (2020) · British Journal of Clinical Pharmacology

Forensic Toxicology and Drug AnalysisPoisoning and overdose treatments

Cited by 73

Assessing the 2004–2018 Fentanyl Misusing Issues Reported to an International Range of Adverse Reporting Systems

Schifano, F., Chiappini, S., Corkery, J. M., & Guirguis, A. (2019) · Frontiers in Pharmacology

Pharmacovigilance and Adverse Drug ReactionsOpioid Use Disorder Treatment

Cited by 55

Novel Opioids: Systematic Web Crawling Within the e-Psychonauts’ Scenario

Arillotta, D., Schifano, F., Napoletano, F., Zangani, C., Gilgar, L., Guirguis, A., Corkery, J. M., Aguglia, E., & Vento, A. (2020) · Frontiers in Neuroscience

Forensic Toxicology and Drug AnalysisOpioid Use Disorder Treatment

Cited by 37

Focus on Clozapine Withdrawal- and Misuse-Related Cases as Reported to the European Medicines Agency (EMA) Pharmacovigilance Database

Chiappini, S., Schifano, F., Corkery, J. M., & Guirguis, A. (2020) · Brain Sciences

Pharmacovigilance and Adverse Drug ReactionsSchizophrenia research and treatment

Cited by 33

Evolutionary Considerations on the Emerging Subculture of the E-psychonauts and the Novel Psychoactive Substances: A Comeback to the Shamanism?

Orsolini, L., St John-Smith, P., McQueen, D., Papanti, D., Corkery, J., & Schifano, F. (2017) · Current Neuropharmacology

Psychedelics and Drug StudiesForensic Toxicology and Drug Analysis

Cited by 28

The consequences of drug misuse on post-marketing surveillance

Schifano, F., Papanti, G. D., Orsolini, L., & Corkery, J. M. (2016) · Expert Review of Clinical Pharmacology

Pharmacovigilance and Adverse Drug ReactionsForensic Toxicology and Drug Analysis

Cited by 21